about
Epileptic seizure after treatment with thiocolchicosideUnited airway disease: current perspectivesCarboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1/2 mutation.Difficult-to-control asthma management through the use of a specific protocolThe hammock: a reservoir of allergens.Brazilian guidelines for the diagnosis and treatment of hereditary angioedema.Increased NY-ESO-1 expression and reduced infiltrating CD3+ T cells in cutaneous melanoma.Sensitization by subcutaneous route is superior to intraperitoneal route in induction of asthma by house dust mite in a murine modeComorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis.Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy.Angioedema associated with nonsteroidal anti-inflammatory drugs.Immediate Hypersensitivity Reaction to Chemotherapeutic Agents.The Complex Interaction Between Polycystic Ovary Syndrome and Hereditary Angioedema: Case Reports and Review of the Literature.Development of an animal model for allergic conjunctivitis: influence of genetic factors and allergen concentration on immune response.Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.Fluticasone furoate nasal spray in the treatment of allergic rhinitis.Clinical and laboratory improvement after intravenous immunoglobulin in drug reaction with eosinophilia and systemic symptoms.Ketoconazole allergy.Asthma studies should be phenotype specific.Animal models of asthma: utility and limitations.Esophageal candidiasis--an adverse effect of inhaled corticosteroids therapy.381 Adverse Drug Reactions in Hospitalized Patients.375 Non-steroidal Anti-inflammatory Drugs Hypersensitivity: Patterns of Reaction.A new humanized in vitro model of IgE-mediated rapid desensitization.Desensitization induces hyporesponsiveness and cell-surface phenotype changes on mouse mast cells.Basophil activation test in allergic patients to platins undergoing rapid desensitization.Humoral biomarkers of latex allergy.Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptoms.315 Diagnosis of Gastroesophageal Reflux Disease in Patients with Chronic Cough.Clinical presentation and markers of cutaneous versus systemic mastocytosis: the mastocytosis center at brigham and women's hospital in Boston.517 Specific IgE to Recombinant Allergens of Latex and Foods in Patients With Spina Bifida.Persistence of positive skin test 25 years after a penicillin-induced anaphylaxis.37 Features of 51 Patients With Perioperative Anaphylaxis History.293 Sensitization of Severe Allergic Asthma Patients.38 Drug Induced Anaphylaxis in a University Hospital in Sao Paulo, Brazil.Desensitization induces hyporesponsiveness and cell-surface phenotype changes on wild-type and humanized mouse mast cells.Drug-induced anaphylaxis: is it an epidemic?Atopy Is Associated with Age at Asthma Onset in Elderly Patients.Aerobic training decreases bronchial hyperresponsiveness and systemic inflammation in patients with moderate or severe asthma: a randomised controlled trial.
P50
Q24647681-357AB9DF-1F30-45E6-8340-4512A6713DF1Q26743436-0195D82E-0513-47CB-B03F-B292243A0EDAQ33571034-8FE4B956-43F9-41DA-B0DA-74B97E7A0F74Q34197997-B340E34A-65B6-4C5E-89B8-025081666AE3Q35141946-E5869328-A2C3-4F52-BF76-BD4AB8A7C82DQ35188409-9FC2D6FE-7736-4CB2-80FA-18F9E671F475Q35543740-EF244384-2AE5-4946-BCD3-A3299473CFE5Q36931539-0C957F1E-EA09-4B51-AEF7-0D04BCF02E61Q37308652-08D9369F-7BCD-48BC-8B97-C3754D011C47Q38103974-671037EA-F398-453D-A9F3-551B7AE77880Q38132699-E820459E-FD4D-4F5D-8417-40890A7D4B2BQ38881681-6B3123C0-418A-44AF-A67A-4D4EFC325996Q39291758-9161DEA0-3880-45D1-984E-93275ADB8FE8Q39438882-D85BACF8-6C34-4C41-90C4-D6F3261FD130Q40054443-BEB069AC-A03B-454F-90ED-ABAD4A9D841FQ40149853-457F84B2-813A-4038-A489-FAFE7CDFC353Q41714251-CE8DD0F5-56AF-4354-9D42-492F75AEAD61Q42235473-54B34224-7EC9-4C4A-AE79-1663C2B3E29EQ43114297-E40580EF-7EBC-4F4B-9364-AE9CF779F632Q43744466-A074FF05-5B29-4A06-812D-36391D4FD20CQ44390096-B4930982-6628-4EA7-8E5F-22D20C55F702Q44537426-2ADEFA66-5A38-4FA7-B708-F77BF4C7BB42Q45794060-DED47403-B6E2-46BF-9B87-3208CD0FC557Q45799812-5E099B5F-AE8B-4521-9A42-328CB4E162A5Q45955855-1AF3809E-93DE-4BF0-9398-E8E8103DF496Q46062125-FBFC4834-0F53-4105-A9BD-6D2EAE8DC06FQ46064800-5880EAC8-979B-4D2F-A83A-E007EED21AA2Q46067002-D03122B2-087F-4861-BB4E-6A7EB297A7BFQ46274698-EC3CD68D-8B66-4591-9771-0D294CF18A66Q46817877-6D91D592-9ED9-47C9-B993-A16050A63E01Q46893389-FA5D5FBA-BC93-4E72-95A5-DA05B6D47D80Q46897377-98449C02-E0E0-4756-A73A-E1BCD7E5BB32Q47110099-3706F8F7-5B7C-4CC4-9F27-145BF8D8D499Q47122881-F5DC027B-8F81-47B8-8BCC-43A7921497C0Q47124718-AC8EE002-9F30-463B-B338-7D677A4CFB41Q47151586-4DAAB059-C6CD-4256-B19B-7B944DA8776FQ47279671-C69DBE05-D53D-41BA-BCB4-31CC4C2AEDFCQ47601208-81316CE2-4B53-4CE7-BC89-A7F7E0DA2172Q47699729-94F0B193-BDC7-431A-A9B6-58638C426733Q48034290-FE547E6C-F4DD-4982-BFDC-5DEDA0F636FF
P50
description
researcher ORCID ID = 0000-0002-1034-7580
@en
wetenschapper
@nl
name
Pedro Giavina-Bianchi
@ast
Pedro Giavina-Bianchi
@en
Pedro Giavina-Bianchi
@es
Pedro Giavina-Bianchi
@nl
type
label
Pedro Giavina-Bianchi
@ast
Pedro Giavina-Bianchi
@en
Pedro Giavina-Bianchi
@es
Pedro Giavina-Bianchi
@nl
prefLabel
Pedro Giavina-Bianchi
@ast
Pedro Giavina-Bianchi
@en
Pedro Giavina-Bianchi
@es
Pedro Giavina-Bianchi
@nl
P106
P21
P31
P496
0000-0002-1034-7580